Endophytes, microorganisms that reside internal tissues of all plant species, are a proven source of novel organic natural molecules, presumed to emphasizing the frontiers of drug discovery. Next to the clinically acknowledged antineoplastic agent, taxol, endophyte research has yielded potential drug, given compounds with antimicrobial, antioxidant, antiviral, antidiabetic, anti-alzheimer's disease and immunosuppressant etc. These evidences arises a hope to combat incurable diseases, drug resistance, other challenges related to human health. The potential of finding new drugs that may be effective candidates for treating newly developing diseases in humans is great. This paper focuses particularly need for new useful compounds from endophytes, the recent role of new disease, recent scenario of screening approach for novel drug and their pharmacological interest. It also describes these compounds by different functions, including some examples that illustrate the potential for human use.
2021 Conference Announcement: Journal of Immunobiology
2021 Conference Announcement: Journal of Immunobiology
Research Article: Journal of Immunobiology
Research Article: Journal of Immunobiology
Case Report: Journal of Immunobiology
Case Report: Journal of Immunobiology
Review Article: Journal of Immunobiology
Review Article: Journal of Immunobiology
Editorial: Journal of Immunobiology
Editorial: Journal of Immunobiology
Posters & Accepted Abstracts: Medical Microbiology & Diagnosis
Posters & Accepted Abstracts: Medical Microbiology & Diagnosis
Scientific Tracks Abstracts: Medical Microbiology & Diagnosis
Scientific Tracks Abstracts: Medical Microbiology & Diagnosis
Posters & Accepted Abstracts: Medical Microbiology & Diagnosis
Posters & Accepted Abstracts: Medical Microbiology & Diagnosis
Keynote: Medical Microbiology & Diagnosis
Keynote: Medical Microbiology & Diagnosis
Keynote: Medical Microbiology & Diagnosis
Keynote: Medical Microbiology & Diagnosis
Journal of Immunobiology received 34 citations as per Google Scholar report